Abstract

Objective:

In the beginning of the coronavirus disease-2019 (COVID-19) pandemic, secondary bacterial, fungal and viral infections have been reported in the intensive care unit (ICU), but there is limited experience with infections in critically ill patients over time. The aim this study was to evaluate the characteristics of secondary infections related to ICU and their effects on mortality in COVID-19 patients.

Materials and Methods:

Our study was planned as a retrospective single-center case-control study involving 145 patients with severe severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pneumonia hospitalized in the ICU between March and June 2020. The epidemiological, clinical and microbiological characteristics and results of ICU-related infections were evaluated.

Results:

The mean age of the patients was 61.2 years and mean body mass index was 28 kg/m2. At least one comorbidity was found in 140 patients (96.6%). Seventy seven of (53.1%) the patients diagnosed with COVID-19 included in the study died. In addition to SARS-CoV-2, the isolation of different pathogens was observed in 62 (42.75%) patients’ samples. In the group with secondary infections, a significant increase in lymphocyte and lactate levels was observed between the time of admission and time of sampling culture (p<0.001). There was statistical significance in lymphocyte (p<0.026 ) and lactate (p<0.020) levels between the groups with and without infection. There was a significant increase in C-reactive protein, ferritin, procalcitonin levels and Acute Physiology and Chronic Health Evaluation-II scores in the group with secondary infection compared to the group without secondary infection (p<0.041, p<0.009 p<0.001, and p=0.028, respectively). In the group without secondary infection, the D-dimer levels patients were significantly lower (p<0.014).

Conclusion:

In conclusion, bacterial and fungal secondary infections are a common complication in patients with COVID-19 admitted to the ICU. It usually occurs as a severe form of infection accompanying comorbidity and is associated with high mortality and prolonged ICU stay.

Keywords: COVID-19, intensive care unit, co-infection, mortality

References

  1. World Health Organization (WHO). Coronavirus disease 2019 Situation Report 51 11th March 2020. World Heal Organ. 2020;2019(March):2633.
  2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020;382:727-33.
  3. Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J, et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect 2020;81:e16-25.
  4. Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect 2020;81:266-75.
  5. Paget C, Trottein F. Mechanisms of Bacterial Superinfection Post-influenza: A Role for Unconventional T Cells. Front Immunol 2019;10:336.
  6. Lai CC, Wang CY, Hsueh PR. Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect 2020;53:505-12.
  7. Avan Mutlu T, Bozok T. Identification of Bacterial Agents Isolated from Lower Respiratory Samples of COVID-19 Patients and Investigation of their Antibacterial Resistance Patterns. Turk Mikrobiyol Cemiy Derg 2022;52:48-55.
  8. Bardi T, Pintado V, Gomez-Rojo M, Escudero-Sanchez R, Azzam Lopez A, Diez-Remesal Y, et al. Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome. Eur J Clin Microbiol Infect Dis 2021;40:495-502.
  9. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;8:475-81.
  10. Ferrando C, Mellado-Artigas R, Gea A, Arruti E, Aldecoa C, Bordell A, et al. Patient characteristics, clinical course and factors associated to ICU mortality in critically ill patients infected with SARS-CoV-2 in Spain: A prospective, cohort, multicentre study. Rev Esp Anestesiol Reanim (Engl Ed) 2020;67:425-37.
  11. Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA 2016;315:788-800.
  12. Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. JAMA 2020;323:2085-6.
  13. Contou D, Claudinon A, Pajot O, Micaëlo M, Longuet Flandre P, Dubert M, et al. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann Intensive Care 2020;10:119.
  14. Cox MJ, Loman N, Bogaert D, O’Grady J. Co-infections: potentially lethal and unexplored in COVID-19. Lancet Microbe 2020;1:e11.
  15. Tayşi MR, Yıldırım F. COVID-19 hastalarında ko-enfeksiyonlar ve sekonder enfeksiyonlar: sıklığı ve yönetimi. In: Ekicibaşı ME, editor. COVID-19 ve Sağlık Araştırmaları 1. İstanbul, Efe Akademi Yayınları; 2021. p. 86-95.
  16. Lehmann CJ, Pho MT, Pitrak D, Ridgway JP, Pettit NN. Community-acquired Coinfection in Coronavirus Disease 2019: A Retrospective Observational Experience. Clin Infect Dis 2021;72:1450-2.
  17. Klein EY, Monteforte B, Gupta A, Jiang W, May L, Hsieh YH, et al. The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis. Influenza Other Respir Viruses 2016;10:394-403.
  18. Garazzino S, Montagnani C, Donà D, Meini A, Felici E, Vergine G, et al. Multicentre Italian study of SARS-CoV-2 infection in children and adolescents, preliminary data as at 10 April 2020. Euro Surveill 2020;25:2000600.
  19. Lim YK, Kweon OJ, Kim HR, Kim TH, Lee MK. Impact of bacterial and viral coinfection in community-acquired pneumonia in adults. Diagn Microbiol Infect Dis 2019;94:50-4.
  20. Brockmeier SL, Loving CL, Nicholson TL, Palmer MV. Coinfection of pigs with porcine respiratory coronavirus and Bordetella bronchiseptica. Vet Microbiol 2008;128:36-47.
  21. Martins-Filho PR, Tavares CSS, Santos VS. Factors associated with mortality in patients with COVID-19. A quantitative evidence synthesis of clinical and laboratory data. Eur J Intern Med 2020;76:97-9.

Copyright and license

Copyright © 2022 The Author(s). This is an open access article distributed under the Creative Commons Attribution License (CC BY), which permits unrestricted use, distribution, and reproduction in any medium or format, provided the original work is properly cited.

How to cite?

1.
Tekdöş Şeker Y, Yeşilbağ Z, Güngördü E, Çukurova Z. The Effect of Secondary Infections on Mortality in Patients with COVID-19 Associated Severe ARDS. Turk J Intensive Care. 2022;20:62-70. https://doi.org/10.4274/tybd.galenos.2022.78942